| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
1- ((3- (3- chloro- 2- hydroxyproxy)- 1- methoxy)propyl)- 5- fluorouracil
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: a derivative of 5-fluorouracil
Also Known As:QF-3602
Bio-Agent Context: Research Results
Related Diseases
| 1. | Rhabdomyosarcoma
09/01/2000
- "In this work, we compared the degree of myogenic differentiation of RD rhabdomyosarcoma (RMS) cells after treatment with QF-3602 and 5-FU"
Get all the results and reference details, order at left... |
| 2. | Neoplasms (Cancer)
09/01/2000
- "Moreover, polymerase chain reaction (PCR) analyses showed that QF-3602 did not induce overexpression of the mdr 1 gene, a resistance mechanism that frequently appears in classical cytotoxic therapy in these tumors"
Get all the results and reference details, order at left... |
| 2 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Fluorouracil (Carac)
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Related Therapies and Procedures
| 1. | Aftercare (After-Treatment)
|
| 1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface Subscription
- Unlimited Searches
- 2 clicks from Disease to Drug to Evidence
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface Subscription
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |